Biomarker & Intervention Discovery

Tension Headache / Chronic Daily Headache

Pharmacologically actionable gene targets, therapeutic agents ranked by evidence tier, and active clinical trials.

Disease Overview

Spontaneous remission
Not established
Best-intervention remission
Gap size
Primary barrier
Biomarker Targets & Therapeutic Agents

Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.

GRIN2B 238PTGS2 299SCN9A 271TRPV1 160
Therapeutic Agent Effect Direction Evidence Tier Potency Source
DIMIRACETAM ? unclear Mechanistic
KETAMINE HYDROCHLORIDE inhibits Mechanistic
PERZINFOTEL inhibits Mechanistic
[3H]CGP39653 inhibits Mechanistic
PHENCYCLIDINE inhibits Mechanistic
DEXANABINOL ? unclear Mechanistic
RAPASTINEL activates Mechanistic
DELUCEMINE inhibits Mechanistic
AMANTADINE HYDROCHLORIDE inhibits Mechanistic
RISLENEMDAZ inhibits Mechanistic
ORPHENADRINE CITRATE inhibits Mechanistic
ELIPRODIL ? unclear Mechanistic 13.0 nM (Ki)
INDANTADOL ? unclear Mechanistic
SEVOFLURANE ? unclear Mechanistic
SAGE-718 ~ modulates Mechanistic
L689560 inhibits Mechanistic
ONFASPRODIL ~ modulates Mechanistic
HOMOQUINOLINIC ACID activates Mechanistic
NEBOGLAMINE ~ modulates Mechanistic
DIZOCILPINE inhibits Mechanistic
LY233053 inhibits Mechanistic
GLYCINE activates Mechanistic
ESKETAMINE ~ modulates Mechanistic
[3H]CGP61594 inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic
[3H]MDL105519 inhibits Mechanistic
RADIPRODIL ? unclear Mechanistic
NBQX ? unclear Mechanistic
SEMAPIMOD inhibits Mechanistic
SELFOTEL inhibits Mechanistic
SERINE, D- activates Mechanistic
COMPOUND 18C [PMID: 25901531] inhibits Mechanistic
AZD8108 inhibits Mechanistic
[3H]L689560 inhibits Mechanistic
TRAXOPRODIL inhibits Mechanistic 74.0 nM (IC50)
HALOPERIDOL DECANOATE ? unclear Mechanistic
N1-DANSYL-SPERMINE inhibits Mechanistic
[3H]D-ASPARTIC ACID activates Mechanistic
NERAMEXANE ? unclear Mechanistic
NVP-AAM077 inhibits Mechanistic

Showing top 40 of 238 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
CARPROFEN inhibits Mechanistic 102.0 nM (IC50)
INDOMETHACIN SODIUM inhibits Mechanistic
DARBUFELONE ? unclear Mechanistic
MEFENAMIC ACID inhibits Mechanistic
MECLOFENAMATE SODIUM inhibits Mechanistic
DICLOFENAC SODIUM inhibits Mechanistic
CAPECITABINE ? unclear Mechanistic
PIRPROFEN inhibits Mechanistic
ESFLURBIPROFEN inhibits Mechanistic
SULFASALAZINE inhibits Mechanistic
BROMFENAC ? unclear Mechanistic
IBUPROFEN, SODIUM SALT inhibits Mechanistic
ALOXIPRIN inhibits Mechanistic
TENOXICAM ? unclear Mechanistic
FLURBIPROFEN inhibits Mechanistic
SALICYLIC ACID ? unclear Mechanistic
ATENOLOL ? unclear Mechanistic
DEXKETOPROFEN inhibits Mechanistic
ETORICOXIB inhibits Mechanistic
LUMIRACOXIB inhibits Mechanistic
SUPROFEN inhibits Mechanistic
NS-398 ? unclear Mechanistic
NABUMETONE inhibits Mechanistic
URSOLIC ACID ? unclear Mechanistic
IBUPROFEN LYSINE inhibits Mechanistic
ACECLOFENAC inhibits Mechanistic
IBUFENAC inhibits Mechanistic
BALSALAZIDE ? unclear Mechanistic
DIFLUNISAL inhibits Mechanistic
BALSALAZIDE DISODIUM inhibits Mechanistic
VACCINE ? unclear Mechanistic
KETOROLAC TROMETHAMINE inhibits Mechanistic
BENZYDAMINE HYDROCHLORIDE inhibits Mechanistic
TIAPROFENIC ACID ? unclear Mechanistic
RALOXIFENE HYDROCHLORIDE ? unclear Mechanistic
NAPROXCINOD inhibits Mechanistic
IGURATIMOD inhibits Mechanistic
ETODOLAC inhibits Mechanistic
DICLOFENAC ETALHYALURONATE SODIUM inhibits Mechanistic
ROFECOXIB inhibits Mechanistic 530.0 nM (IC50)

Showing top 40 of 299 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
MERETHOXYLLINE PROCAINE inhibits Mechanistic
ETIDOCAINE HYDROCHLORIDE inhibits Mechanistic
FOSPHENYTOIN inhibits Mechanistic
VERATRIDINE activates Mechanistic
ORPHENADRINE CITRATE inhibits Mechanistic
PHENACEMIDE inhibits Mechanistic
LACOSAMIDE inhibits Mechanistic
VIXOTRIGINE inhibits Mechanistic
DSP-2230 inhibits Mechanistic
SAXITOXIN inhibits Mechanistic
ESLICARBAZEPINE ACETATE inhibits Mechanistic
SAFINAMIDE ? unclear Mechanistic
LIDOCAINE inhibits Mechanistic
RILUZOLE inhibits Mechanistic
ROPIVACAINE HYDROCHLORIDE inhibits Mechanistic
FUNAPIDE inhibits Mechanistic
DYCLONINE HYDROCHLORIDE inhibits Mechanistic
EVENAMIDE inhibits Mechanistic
PROPOFOL ? unclear Mechanistic
AM-6120 inhibits Mechanistic
RG7893 inhibits Mechanistic
RG6029 inhibits Mechanistic
QUINIDINE SULFATE inhibits Mechanistic
ZONISAMIDE inhibits Mechanistic
NERISPIRDINE inhibits Mechanistic
RALFINAMIDE inhibits Mechanistic
DS-1971A inhibits Mechanistic
HEXYLCAINE HYDROCHLORIDE inhibits Mechanistic
MEPIVACAINE HYDROCHLORIDE inhibits Mechanistic
PROCAINAMIDE HYDROCHLORIDE inhibits Mechanistic
PROPAFENONE HYDROCHLORIDE inhibits Mechanistic
LIDOCAINE HYDROCHLORIDE inhibits Mechanistic
QUINIDINE GLUCONATE inhibits Mechanistic
PRILOCAINE inhibits Mechanistic
ETHOTOIN inhibits Mechanistic
PF-05089771 inhibits Mechanistic
DICHLOROBENZYL ALCOHOL inhibits Mechanistic
RANOLAZINE ? unclear Mechanistic
PRILOCAINE HYDROCHLORIDE inhibits Mechanistic
ORPHENADRINE HYDROCHLORIDE inhibits Mechanistic

Showing top 40 of 271 agents ranked by evidence tier.

Therapeutic Agent Effect Direction Evidence Tier Potency Source
STREPTOZOCIN ? unclear Mechanistic
BENZYL ISOTHIOCYANATE ? unclear Mechanistic
ACETAMINOPHEN activates Mechanistic
POLYGODIAL ? unclear Mechanistic
PROPOFOL ? unclear Mechanistic
SAF312 inhibits Mechanistic
GRC-15300 ? unclear Mechanistic
AZD1386 inhibits Mechanistic
TIVANISIRAN inhibits Mechanistic
MAVATREP inhibits Mechanistic
MR-1817 inhibits Mechanistic
FERRUGINENE B ? unclear Mechanistic
CAPSAICIN activates Mechanistic 19.95 nM (EC50)
RECOMBINANT TUMOR NECROSIS FACTOR FAMILY PROTEIN ? unclear Mechanistic
PHENETHYLISOTHIOCYANATE ? unclear Mechanistic
VOACANGINE ? unclear Mechanistic
RESINIFERATOXIN activates Mechanistic 23.1 nM (Ki)
DWP05195 inhibits Mechanistic
XEN-D0501 inhibits Mechanistic
PAC-14028 inhibits Mechanistic
SB-705498 inhibits Mechanistic
MASOPROCOL ? unclear Mechanistic
ALLYL ISOTHIOCYANATE ? unclear Mechanistic
NGD-8243 inhibits Mechanistic
GRC-6211 inhibits Mechanistic
RESERPINE ? unclear Mechanistic
NABIXIMOLS ? unclear Mechanistic
A425619 ? unclear Mechanistic
PHE377 inhibits Mechanistic
ANTISENSE OLIGONUCLEOTIDES ? unclear Mechanistic
WORTMANNIN ? unclear Mechanistic
JTS-653 inhibits Mechanistic
LEVODOPA ? unclear Mechanistic
AMG517 inhibits Mechanistic
CAPSAZEPINE ? unclear Mechanistic 120.0 nM (Ki)
ZUCAPSAICIN activates Mechanistic
INDOMETHACIN ? unclear Mechanistic
CHEMBL:CHEMBL191534 ? unclear Mechanistic
ABT-102 inhibits Mechanistic
ISOPROPYL ISOTHIOCYANATE ? unclear Mechanistic

Showing top 40 of 160 agents ranked by evidence tier.


Clinical Trials

Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-03.

NCT03231241 Phase: N/A Started: 2014-12-12

Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help ...

NCT00269581 Phase: PHASE3 Started: 2004-08

Purpose of this study is to determine if a CD-ROM computer program (called "Headstrong") is effective in helping children cope with chronic headaches.


Agents Found By Disease-Level Search

Searched directly from “Tension Headache / Chronic Daily Headache” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 4-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).

Not yet run. python -m biomarker_pipeline.run_disease_agent_discovery --disease "..."

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation The OSMF hub — advancing open-source biomedical research infrastructure, tools, and evidence synthesis.
SpikeProtein.site Database and research resource on SARS-CoV-2 spike protein biology, persistence, and clinical implications.
Vaccine Data Navigator Open-access navigation tool for vaccine adverse event reporting and surveillance data.
PACVS Research Summit Annual summit convening researchers, clinicians, and patients on PACVS science.